Calidi Biotherapeutics's total assets for Q4 2023 were $10.02M, a decrease of -46.10% from the previous quarter. CLDI total liabilities were $18.25M for the fiscal quarter, a -7.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.